Jump to ContentJump to Main Navigation

Online

99,00 € / $149.00*

* Prices subject to change. Shipping costs will be added if applicable.
Publication Date:
June 2009
ISSN:
1619-3997
DOI:
10.1515/JPM.2009.082

See all formats and pricing

Online
Individual Subscription Online only
Euro [D] 99.00
RRP for USA, Canada, Mexico
US$ 149.00 *
Print
Individual Subscription Online only
Euro [D] 744.00
RRP for USA, Canada, Mexico
US$ 1116.00 *
Print + Online
Individual Subscription Online only
Euro [D] 893.00
RRP for USA, Canada, Mexico
US$ 1340.00 *
*Prices subject to change. Shipping costs will be added if applicable.

Journal of Perinatal Medicine

Official Journal of the World Association of Perinatal Medicine

Editor-in-Chief: Dudenhausen, Joachim W.

Editorial Board Member: / Bancalari, Eduardo / Greenough, Anne / Genc, Mehmet R. / Chervenak, Frank A. / Aslam, Muhammad / Bergmann, Renate L. / Bernardes, J.F. / Bevilacqua, G. / Blickstein, Isaac / Brezinka, Christoph / Cabero Roura, Luis / Carbonell-Estrany, Xavier / Carrera, Jose M. / D`Addario, Vincenzo / Dimitrou, G. / Foulon, Walter / Grunebaum, G. E. / Harding, Jane / Hentschel, Roland / Kawabata, Ichiro / Keirse, M.J.M.C. / Kurjak M.D., Asim / Levene, Malcolm / Lockwood, Charles J. / Marsal, Karel / Nishida, Hiroshi / Papp, Zoltán / Makatsariya, Alexander / Pejaver, Ranjan Kumar / Pooh, Ritsuko K. / Saugstad, Ola D. / Schenker, Joseph G. / Sen, Cihat / Geijn, Herman P. / Vetter, Klaus / Young, Bruce K. / Zimmermann, Roland / Köpcke, W.

6 Issues per year

IMPACT FACTOR 2011: 1.702
5-year IMPACT FACTOR: 1.779
Rank 36 out of 79 in category Obstretics and Gynecology and 45 out of 113 in category Pediatrics in the 2011 Thomson Reuters Journal Citation Report/Science Edition

VolumeIssuePage

Issues

Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus

Marco Scioscia1, 2 / Khalid Gumaa3 / Luigi E. Selvaggi4 / Charles H. Rodeck2 / Thomas W. Rademacher1

1Department of Immunology and Molecular Pathology, Molecular Medicine Unit, Royal Free and University College Medical School, London, UK

2Department of Obstetrics and Gynecology, Royal Free and University College Medical School, London, UK

3College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain

4Department of Obstetrics and Gynecology, University of Medical Science of Bari, Bari, Italy

Corresponding author: Dr. Marco Scioscia Department of Obstetrics and Gynecology Sacro Cuore Don Calabria General Hospital Via Don A. Sempreboni 5, 37024 Negrar (VR) Italy Tel.: +39 349 872 4206 Fax: +39 045 750 0480

Citation Information: Journal of Perinatal Medicine. Volume 37, Issue 5, Pages 469–471, ISSN (Online) 1619-3997, ISSN (Print) 0300-5577, DOI: 10.1515/JPM.2009.082, June 2009

Publication History:
Received:
2008-12-30
Accepted:
2009-03-19
Published Online:
2009-06-03

Abstract

A progressive insulin resistant state develops throughout human pregnancy. Inositol phosphoglycan P-type (P-IPG), a second messenger of insulin, was reported to negatively correlate with the degree of insulin resistance in non-pregnant diabetic subjects. Urinary levels of P-IPG were assessed in insulin resistant states during pregnancy such as gestational diabetes mellitus (GDM, n=44) and type 2 diabetes mellitus (type 2 DM, n=25) and in 69 normal pregnant women. Urinary levels of P-IPG were higher in GDM than controls with a positive trend of release throughout normal pregnancy (P<0.01). P-IPG excretion was higher in diabetic (GDM and type 2 DM) than in healthy women in the second trimester (P<0.05). A higher P-IPG urinary excretion occurs during the second trimester in pregnant women with clinically evident insulin resistance with a positive association with poor glycemic control.

Keywords: Diabetes type 2; gestational diabetes mellitus; glycemic control; inositol phosphoglycan; pregnancy

Comments (0)

Please log in or register to comment.